Everyone ages; one’s health and quality of life can differ greatly between individuals. The physical appearance of aging, while a universal concern, is merely an issue of aesthetics. However, the effects of getting older begin at the genetic level. One company tackling the effects of aging, including age-related diseases, such as heart disease, cancer and diabetes is the innovative biotechnology company, CohBar Inc. ($COB.U) (CWBR) The breakthrough research by one of their founders, Dr. Nir Barzilai has not only captured the attention of the medical world, it has caught the attention of a major Hollywood player.
CohBar founder Dr. Nir Barzilai will be featured in the upcoming National Geographic Channel’s new docu-series, Breakthrough. Executive Produced by film director Ron Howard,Breakthrough will cover various developments in the scientific community. Howard directed the The Age of Aging episode featuring CohBar’s Dr. Barzilai that focuses on his research in understanding the science of aging.
“I wanted to tackle aging because it’s so universal,” said Howard. “It’s a question that’s been asked forever. It begs some philosophical questions as well. We’re all obviously preoccupied with it. Even when we’re young and think it won’t relate to us, there are going to be loved ones and people we care about who are navigating that part of their lives.”
CohBar’s mission is to treat major diseases and extend healthy life spans through the breakthrough discovery of novel Mitochondrial-Derived Peptides (“MDPs”) and the advancement of their development into clinically relevant and commercially successful therapeutics. Fortune magazine estimated that a drug that helps prevent age-related diseases could be worth $25 billion annually. Currently, the company’s founder, Dr. Nir Barzilai, aims to persuade the FDA to approve a proposed anti-aging clinical trial.
Through National Geographic’s reputation as a world-renowned educational media outlet, CohBar founder Dr. Barzilai’s revolutionary work will be highlighted on national television. Future generations may not only be able to live longer, but, overall, live better, healthier lives.
“Interestingly, the goal isn’t simply to extend life,” said Howard. “It’s entirely about the extension of quality time, of years when someone can be highly productive and apply what he or she knows and has learned in a very active way. The research really focuses on delaying the onset of the diseases of aging, like heart disease, diabetes, cancer, and Alzheimer’s. That’s the way to enrich lives.”
This six episode National Geographic Channel series, beginning Thanksgiving weekend, will air on Sundays through December 13. CohBar founder Dr. Barzilai will be featured in the The Age of Aging episode on November 29th at 6:00 pm PST.
For more information about CohBar, visit www.cohbar.com.
Disclosure: In the purview of Section 17(B) of the Securities Act of 1933 and in the interest of full disclosure, we call the reader's attention the fact that Equities.com, Inc. may be compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker, broker dealer, investment advisor, analyst, investment banker or underwriter. All profiles are based on information that is available to the public. The information contained herein should not be considered to be all-inclusive and is not guaranteed by Equities.com to be free from misstatement or errors. Readers are reminded to do their own due diligence when researching any companies mentioned on this website.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer